VolitionRX (VNRX) vs Vivos Therapeutics (VVOS)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
VolitionRX is the larger company by market cap ($6.7 million vs $5.3 million), about 1.3 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | VNRX | VVOS |
|---|---|---|
| Share price | $0.2234 | $0.1579 |
| Market cap | $6.72M | $5.31M |
| 1-day change | +1.81% | +5.62% |
| EPS (TTM) | $-3.80 | $-1.88 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $10.40 | $3.28 |
| 52-week low | $0.22 | $0.129 |
| Distance from 52-week high | -97.85% | -95.19% |
| Analyst consensus | none | none |
| Avg. price target upside | +5996.69% | +1242.62% |
| Average volume | 8.47M | 12.57M |
| Shares outstanding | 30.06M | 33.61M |
| Employees | 57 | 268 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About VolitionRX
VNRX stock →VolitionRx Limited, a multi-national epigenetics company, develops blood tests to help detect and monitor a range of cancers, and diseases associated with NETosis in the United States, Europe, and Asia. The company offers Nu.Q Vet, a cancer screening test for dogs and other animals; Nu.Q Nets, detects diseases associated with NETosis, such as sepsis; Nu.Q Discover, a solution to profiling nucleosomes.
Health Care · Biotechnology: In Vitro & In Vivo Diagnostic Substances · 57 employees
About Vivos Therapeutics
VVOS stock →Vivos Therapeutics, Inc. operates as a medical technology and healthcare services company that develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults.
Health Care · Medical/Dental Instruments · 268 employees
VNRX vs VVOS FAQ
Which is bigger, VolitionRX or Vivos Therapeutics?
VolitionRX (VNRX) is larger, with a market capitalization of $6.72M compared with $5.31M for Vivos Therapeutics (VVOS).
Are VolitionRX and Vivos Therapeutics in the same industry?
Both are in the Health Care sector, but in different industries: Biotechnology: In Vitro & In Vivo Diagnostic Substances for VolitionRX and Medical/Dental Instruments for Vivos Therapeutics.